Effects of denosumab on peripheral lymphocyte subpopulations
Year:
2016
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Referee:
No
Name of journal:
ENDOCRINE
ISSN of journal:
1355-008X
N° Volume:
53
Number or Folder:
3
Page numbers:
857-859
Keyword:
denosumab, lymphocyte, rheumatoid arthritis
Short description of contents:
The development of denosumab, a human monoclonal antibody to receptor activator of nuclear factor kappa B ligand (RANKL), represents a novel approach to the prevention of fragility fractures in osteoporosis, skeletal complications of malignancy, and bone erosions in rheumatoid arthritis